Brief Mindfulness and Nutrition-Based Interventions for Chronic Pain: Strategies to Ease Pain (STEP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03563911|
Recruitment Status : Withdrawn (COVID pandemic)
First Posted : June 20, 2018
Last Update Posted : December 7, 2020
|Condition or disease||Intervention/treatment||Phase|
|Opioid Use Chronic Pain||Behavioral: Brief Mindfulness-Based Intervention (BMBI) Behavioral: Control/Nutrition Education||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Brief Mindfulness-Based Intervention for Chronic Pain: A Pilot Randomized Clinical Trial|
|Actual Study Start Date :||December 12, 2018|
|Actual Primary Completion Date :||April 1, 2020|
|Actual Study Completion Date :||April 1, 2020|
Experimental: Brief Mindfulness-Based Intervention
Those assigned to the Brief Mindfulness-Based Intervention (BMBI) Arm will receive BMBI.
Behavioral: Brief Mindfulness-Based Intervention (BMBI)
The BMBI is be based on a BMBI which demonstrated analgesic effects in a previous study. Relative to full-length interventions, we will employ a brief intervention; the 20-minute BMBI session will include education on the foundational concepts of mindfulness and its relevance to chronic pain (5 minutes) and a guided mindfulness practice involving focused attention on the breath and monitoring of thoughts, feelings, and body sensations (15 minutes). BMBI participants will be encouraged to practice the taught mindfulness technique at home at least 20 minutes/day for 1 week (a handout and link to an online guided mindfulness practice will be provided).
Active Comparator: Control/Nutrition Education
Those assigned to the Control/Nutrition Education Arm will receive the nutrition education intervention.
Behavioral: Control/Nutrition Education
The Control intervention will involve nutrition education, adapted from an existing manual of cognitive-behavioral therapy for opioid-treated chronic pain. Control intervention protocol will match the BMBI in terms of time / structure to control for the non-specific, non-mindfulness effects of BMBI. The 20-minute Control session will include education on the relationship between diet and pain (10 minutes) and recommendations for a healthy diet (10 minutes). Control participants will be encouraged to prepare healthy meals at home at least 20 minutes/day for 1 week (a handout and link to online resources will be provided).
- Cold pressor testing [ Time Frame: 1 hour ]Cold pressor testing will be used to characterize pain processing (e.g., pain threshold, pain tolerance, pain severity). In the cold pressor test, a participant is asked to place his or her hand and forearm in an ice bath until the pain is too great to remain in the water. Consistent with past research, a 15 liter refrigerated circulator (Polyscience MX15R-30-A11B) with water temperature set as low as 1°C will be used in the present study.
- Pressure algometer testing [ Time Frame: 1 hour ]Pressure algometer testing will be used to characterize pain processing (e.g., pain threshold, pain tolerance, pain severity). In the pressure algometer test, the algometer is used to apply pressure to the skin until the pain can no longer be tolerated. In the current study, we will utilize a device widely used in alogmeter pain research (Wagnder Force One Alogmeter FIPX).
- Brief Pain Inventory [ Time Frame: 4 weeks ]Measures: 1) pain severity= mean of items 3-6 (ranges from 0-10 with higher scores indicating greater pain severity), and 2) pain interference= mean of items 9A-9G (ranges from 0-10 with higher scores indicating greater pain interference).
- Hospital Anxiety and Depression Scale [ Time Frame: 4 weeks ]Measures: 1) Anxiety (sum of 7 items; ranges from 0-21, with higher scores indicating greater anxiety), and 2) Depression (sum of 7 items; ranges from 0-21, with higher scores indicating greater depressive symptoms).
- Mindful Attention Awareness Scale [ Time Frame: 4 weeks ]Measures mindfulness; mean of 15 items (ranges from 1 to 6, with higher scores indicating greater levels of mindfulness)
- Schwartz Outcome Scale [ Time Frame: 4 weeks ]Measures general well-being; sum of 10 items (ranges from 0 to 60, with higher scores indicating greater well-being)
- Toronto Mindfulness Scale-Decentering Subscale [ Time Frame: 1 hour ]Measures decentering; sum of 7 items (higher scores indicate greater levels of decentering)
- Opioid Compliance Checklist [ Time Frame: 4 weeks ]Measure misuse of opioid medications (scores range from 0 to 12, with higher scoring indicating greater misuse)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03563911
|United States, Wisconsin|
|University of Wisconsin|
|Madison, Wisconsin, United States, 53715|